Crossover Study May Show Dose Response For Inhaled Steroids - FDA Cmte.
Executive Summary
A crossover study may be one way to show dose response in bioequivalence studies for inhaled corticosteroids, members of the Orally Inhaled & Nasal Drugs Subcommittee of FDA's Pharmaceutical Sciences Advisory Committee agreed at a recent meeting.
You may also be interested in...
Muro/Adams Tri-Nasal Launch Planned For Fall Allergy Season With 250 Reps
Muro Pharmaceuticals is increasing production to launch its Tri-Nasal intranasal steroid medication by the start of the fall allergy season.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011